Investigation on staging of breast cancer using miR-21 as a biomarker in the serum
by Bindu Salim; M.V. Athira; A. Kandaswamy; Madhulika Vijayakumar
International Journal of Biomedical Engineering and Technology (IJBET), Vol. 33, No. 3, 2020

Abstract: Circulating microRNAs (miRNA) are a novel class of stable, minimally invasive disease biomarkers that are valuable in diagnostics and therapeutics. miR-21 is an oncogenic miRNA that regulates the expression of multiple cancer-related target genes and it is highly expressed in the patients' serum suffering from breast cancer. The focus of the present study was on measuring the expression profile of the most significantly up-regulated miR-21 in breast cancer patients' serum to evaluate their correlation with the clinical stage of cancer by using a molecular beacon probe. miR-21 expression was also quantitatively analysed by TaqMan real-time PCR techniques. Ten serum samples from the confirmed breast cancer patients and one healthy control sample were used for the evaluation of miR-21 gene expression. The expression levels of miR-21 were significantly higher in breast cancer serum samples compared to healthy control samples with significant differences corresponding to clinical stages of II, III, and IV. The findings indicate that serum miR-21 would serve as a potential marker for therapeutic regimes as well as monitoring the patient status by a simple blood test.

Online publication date: Wed, 17-Jun-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biomedical Engineering and Technology (IJBET):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com